About 200 reports

  • Interventional oncology market: Opportunity assessment
  • Key highlights of interventional oncology market

About Interventional Oncology Interventional oncology procedures involve the diagnosis and treatment of cancer and cancer-related problems by using minimally invasive (MI) procedures performed under image guidance. Interventional oncology uses X-ray, ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to...

  • Oncology
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Terumo Corporation

Oncology Information System Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022 ##.

  • General Medicine And Specialty Medicine
  • Oncology
  • World
  • Market Shares

VARIAN: PRODUCT PORTFOLIO List of Figures FIGURE ##.

  • General Medicine And Specialty Medicine
  • Oncology
  • APAC
  • World
  • Forecast
  • ONCOLOGY TESTING GLOBAL MARKET REVENUE, BY CANCER TYPE (2016-2024) ($MN)
  • EUROPE ONCOLOGY TESTING MARKET REVENUE, BY CANCER TYPE (2016-2024) ($MN)

Liquid biopsy is process of obtaining non-solid tissue usually the blood and other body fluids (urine, saliva etc. ) obtained non-invasively as a diagnosis and monitoring tool for disease such as cancer through identification of biomarker in form of cell-fee DNA or circulating tumor cells (CTC) to advance personalized...

  • Oncology
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.

It' s the one and only driver of biosimilar usage in the US. " - US key opinion leader Answering key questions about oncology biosimilars Quality of evidence is a hurdle to overcome: What’s worrying KOLs about the evidence available for biosimilars?

  • Biosimilar
  • Oncology
  • Oncology
  • Therapy
  • United States
  • ONCOLOGY
  • 44.3% of the Market Share Comes from Oncology

About Radiofrequency Ablation Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic...

  • Oncology
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • Impact of oncology pathways on oncology drug use
  • THE IMPACT OF PATHWAYS ON ONCOLOGY

The costs of treating cancer in the US are spiraling upward, and payers have taken notice. The growing focus on value and quality has driven greater use of clinical pathways: structured, standardized, evidence-based patient management plans that typically favor the most effective, least toxic, and lowest cost treatment options. Providers implement...

  • Health Care Provider
  • Oncology
  • Oncology
  • United States
  • Aetna Inc.
  • IMPACT OF DRIVERS AND CHALLENGES
  • Market drivers

You can easily book an appointment with one online.

  • Oncology
  • AngioDynamics, Inc.
  • Boston Scientific Corporation
  • Ethicon, Inc.
  • Medtronic, Inc.
  • GERMANY
  • SPAIN

According to NCBI, in January 2016, studies conducted by researchers from various universities and hospitals in Germany (Department of Radiation Oncology, University Hospital Erlangen, Department of Radiation Oncology, University Hospital Leipzig, Department of Radiation

  • Hospital
  • Oncology
  • Europe
  • Cianna Medical, Inc.
  • Hologic, Inc.
  • 7.13 Oncology Procedure Volumes (2011-2016)

This TforG report includes the Surgical Procedures Database with 620 surgical interventions, reported by the ICD-9 coding system in Romania. To add context to the surgical procedure volumes, the report provides written and numerical analysis on the current trends, size, changes and dynamics of the local markets. In addition, the latest reforms...

  • Hospital
  • Oncology
  • Romania
  • Demand
  • TforG Group
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY
  • X: MEDICAL ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • Oncology
  • East Asia
  • Japan
  • Forecast
  • Market Size
  • IX: MEDICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • X: MEDICAL ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY
  • IX: GYNECOLOGICAL ONCOLOGY PENETRATION BY GEOGRAPHY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • IX: MEDICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • X: MEDICAL ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY
  • XIII: SURGICAL ONCOLOGY PENETRATION BY GEOGRAPHY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • IX: MEDICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • XIV: RADIATION ONCOLOGY MEAL FREQUENCY
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States
  • The US Oncology Network - Key Facts
  • The US Oncology Network - SWOT Analysis

The US Oncology Network - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Health Services
  • Oncology
  • United States
  • Company
  • McKesson Corporation
  • IX: MEDICAL ONCOLOGY PENETRATION BY GEOGRAPHY
  • VIII: HEMATOLOGY/ONCOLOGY MEAL FREQUENCY

Summary Pharmaceutical sales and marketing organizations face a challenging U.S. environment as physician access becomes increasingly restricted. Despite this major hurdle, personal promotion remains one of the most effective sales and marketing tools and it has never been more critical for drug and device makers to actively...

  • Health Care Provider
  • Healthcare
  • Oncology
  • Therapy
  • United States

Surgical oncology dominated the overall market in terms of share and was valued at over USD ## billion in 2013 majorly on account of high procedure volumes and cancer prevalence.

  • Oncology
  • United States
  • World
  • Forecast
  • Market Size
  • ZIOPHARM Oncology Inc, Subsidiaries
  • ZIOPHARM Oncology Inc, Key Employees

Summary Ziopharm Oncology Inc (Ziopharm), formerly EasyWeb Inc is a biotechnology company that discovers and develops cancer therapies.The company develops novel gene expression, control and cell technologies to provides cell-based therapies for the treatment of cancer and graft-versus-host-disease (GvHD). It offers...

  • Oncology
  • Oncology
  • United States
  • Company
  • ZIOPHARM Oncology, Inc.
  • 21st Century Oncology Inc, Subsidiaries
  • 21ST CENTURY ONCOLOGY ACQUIRES REMAINING 35% STAKE IN SOUTH FLORIDA RADIATION ONCOLOGY

Summary 21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation oncology, breast, gynecological...

  • Oncology
  • Oncology
  • United States
  • M&A
  • GlobalData's company
  • PHYSICIAN ONCOLOGY SERVICES COMPLETES MERGER WITH VANTAGE ONCOLOGY
  • Vantage Oncology Inc, Subsidiaries

Summary Vantage Oncology Inc (Vantage Oncology), a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in the US. It provides treatment for bone, brain, breast, gastrointestinal, gynecological, prostate,...

  • Oncology
  • Oncology
  • United States
  • Deals & Alliance
  • GlobalData's company
  • 21st Century Oncology Inc - Strengths
  • 21st Century Oncology Inc, Key Employees

21st Century Oncology Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Health Services
  • Oncology
  • United States
  • M&A
  • GlobalData's company

Global Tumor Ablation Devices Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## End User Analysis ##. ## Strategic Benchmarking ##. ## Opportun

  • General Medicine And Specialty Medicine
  • Oncology
  • APAC
  • World
  • Forecast

Lumpectomy Market Analysis by End User ##. ## Hospitals ##. ## Oncology Research & Screening Centers ##.

  • Breast Cancer
  • General Medicine And Specialty Medicine
  • Oncology
  • United States

##: cfDNA Reagents, Consumables, and Kits Table ##-##: cfDNA Systems and Software Table ##-##: cfDNA NIPT Products and Services Table ##-##: Oncology cfDNA Products Table ##-##: cfDNA Transplantation Diagnostics Table ##-##: c

  • DNA
  • Genomics
  • Oncology
  • APAC
  • Market Size

Tumour Ablation Devices - Global Market Outlook (2015-2022) ## Executive Summary ## Preface ##. ## Abstract ##. ## Stake Holders ##. ## Research Scope ##. ## Research Methodology ##. ##. ## Data Mining ##. ##. ## Data Analysis ##. ##. ## Data Validation ##. ##. ## Research Approach ##. ## Research Sources ##. ##. ## Primary Resear

  • General Medicine And Specialty Medicine
  • Oncology
  • APAC
  • World
  • Market Size

Hematology/ Oncology, Medical Oncology, Pediatric Medicine, Internal Medicine, and Radiation Oncology) and how does this compare to the overall set of rep-accessible physicians?

  • General Medicine And Specialty Medicine
  • Oncology
  • United States